Indivior warns of bigger hit from copycat drug

July 25 (Reuters) – Indivior said on Wednesday the impact from the launch of a generic version of its opioid addiction treatment “could be materially higher” in 2018, as the British drugmaker posted a second straight drop in quarterly profit.

The company, which issued a profit warning this month citing significant market share loss for star drug Suboxone Film, said adjusted net income fell 21.3 percent to $70 million in the quarter ended June 30 from a year earlier.

Revenue fell 6.9 percent to $268 million in the quarter. (Reporting by Justin George Varghese in Bengaluru Editing by Saumyadeb Chakrabarty)

Learn More about best forex signals review

What do you think?

0 points
Upvote Downvote

Total votes: 0

Upvotes: 0

Upvotes percentage: 0.000000%

Downvotes: 0

Downvotes percentage: 0.000000%

Dozens feared dead, rescuers search for missing after Laos dam collapse

Houthis target Saudi warship off Yemen coast: Al Masirah TV